Hasil Pencarian - Olaf Hopfer
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 4 hasil dari 4
-
1
-
2
-
3
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction ther... oleh Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, Markus Kratzmann, Lukas Baumann, Tim Sauer, Martina Crysandt, Andreas Rank, Dirk Behringer, Lino Teichmann, Martin Görner, Ralf-Ulrich Trappe, Christoph Röllig, Stefan Krause, Maher Hanoun, Olaf Hopfer, Gerhard Held, Sebastian Buske, Lars Fransecky, Sabine Kayser, Christoph Schliemann, Kerstin Schaefer-Eckart, Yousef Al-Fareh, Jörg Schubert, Thomas Geer, Martin Kaufmann, Arne Brecht, Dirk Niemann, Meinhard Kieser, Martin Bornhäuser, Uwe Platzbecker, Hubert Serve, Claudia D. Baldus, Carsten Müller-Tidow, Richard F. Schlenk
Diterbitkan 2021-11-01Dapatkan teks lengkap
Artikel -
4
P1122: A PROSPECTIVE, NON-INTERVENTIONAL STUDY OF REAL-WORLD TREATMENT AND OUTCOME IN SECONDARY CNS LYMPHOMA oleh Stefan Habringer, Uta Demel, Anne-Katrin Fietz, Felicitas Lammer, Roland Schroers, Silvia Hofer, Osnat Bairey, Jan Braess, Anna Sofia Meier-Stiegen, Reingard Stuhlmann, Martin Schmidt-Hieber, Johannes Hoffmann, Bettina Zinngrebe, Ulrich Kaiser, Peter Reimer, Robert Möhle, Peter Fix, Heinz-Gert Höffkes, Ulrich Langenkamp, Christian Meyer Zum Büschenfelde, Olaf Hopfer, Andrea Stoltefuß, Paul La Rosée, Henning Blasberg, Karin Jordan, Stephan Kaun, Meike Unteroberdörster, Ann-Christin von Brünneck, David Capper, Frank L. Heppner, Björn Chapuy, Martin Janz, Stefan Schwartz, Frank Konietschke, Peter Vajkoczy, Agnieszka Korfel, Ulrich Keller
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel